|
🐜
|
Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
15 auth.
Isabella Marie,
S. Josse,
O. Decaux,
S. Dominique,
E. Diot,
C. Landron,
P. Roblot,
S. Jouneau,
P. Hatron,
K. Tiev,
...
O. Vittecoq,
D. Noel,
L. Mouthon,
J. Ménard,
F. Jouen
|
7 |
2012 |
7
🐜
|
|
🐜
|
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
19 auth.
P. Dieudé,
M. Guedj,
J. Wipff,
B. Ruiz,
E. Hachulla,
E. Diot,
B. Granel,
J. Sibilia,
K. Tiev,
L. Mouthon,
...
J. Cracowski,
P. Carpentier,
Z. Amoura,
I. Fajardy,
J. Avouac,
O. Meyer,
A. Kahan,
C. Boileau,
Y. Allanore
|
7 |
2009 |
7
🐜
|
|
🐜
|
Intravenous immunoglobulins for steroid‐refractory esophageal involvement related to polymyositis and dermatomyositis: A series of 73 patients
8 auth.
Isabella Marie,
Jean-François Ménard,
P. Hatron,
E. Hachulla,
Luc Mouthon,
K. Tiev,
...
Philippe Ducrotté,
Patrick Cherin
|
7 |
2010 |
7
🐜
|
|
🐜
|
Infectious complications in polymyositis and dermatomyositis: a series of 279 patients.
7 auth.
I. Marie,
J. Ménard,
E. Hachulla,
P. Cherin,
O. Benveniste,
K. Tiev,
...
P. Hatron
|
6 |
2011 |
6
🐜
|
|
🐜
|
BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
22 auth.
P. Dieudé,
J. Wipff,
M. Guedj,
B. Ruiz,
Inga Melchers,
E. Hachulla,
G. Riemekasten,
E. Diot,
N. Hunzelmann,
J. Sibilia,
...
K. Tiev,
Luc Mouthon,
J. Cracowski,
Patrick Carpentier,
J. Distler,
Z. Amoura,
I. Tarner,
J. Avouac,
O. Meyer,
André Kahan,
Catherine Boileau,
Y. Allanore
|
6 |
2009 |
6
🐜
|
|
🐜
|
Long‐term outcome of patients with polymyositis/ dermatomyositis and anti‐PM‐Scl antibody
13 auth.
Isabella Marie,
L. Lahaxe,
O. Benveniste,
K. Delavigne,
Daniel Adoue,
Luc Mouthon,
E. Hachulla,
Joël Constans,
K. Tiev,
Elisabeth Diot,
...
H. Levesque,
Olivier Boyer,
F. Jouen
|
6 |
2010 |
6
🐜
|
|
🐜
|
NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis
26 auth.
P. Dieudé,
M. Guedj,
J. Wipff,
B. Ruiz,
G. Riemekasten,
P. Airò,
I. Melchers,
E. Hachulla,
M. Cerinic,
E. Diot,
N. Hunzelmann,
P. Caramaschi,
J. Sibilia,
K. Tiev,
L. Mouthon,
...
V. Riccieri,
J. Cracowski,
P. Carpentier,
J. Distler,
Z. Amoura,
I. Tarner,
J. Avouac,
O. Meyer,
A. Kahan,
C. Boileau,
Y. Allanore
|
6 |
2010 |
6
🐜
|
|
🐜
|
Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population.
30 auth.
J. Wipff,
P. Dieudé,
M. Guedj,
B. Ruiz,
G. Riemekasten,
J. Cracowski,
M. Matucci-Cerinic,
I. Melchers,
M. Humbert,
E. Hachulla,
P. Airò,
E. Diot,
N. Hunzelmann,
P. Caramaschi,
J. Sibilia,
...
G. Valentini,
K. Tiev,
B. Girerd,
L. Mouthon,
V. Riccieri,
P. Carpentier,
J. Distler,
Z. Amoura,
I. Tarner,
B. Degano,
J. Avouac,
O. Meyer,
A. Kahan,
C. Boileau,
Y. Allanore
|
5 |
2010 |
5
🐜
|
|
🐜
|
Association of hypoxia‐inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population
13 auth.
J. Wipff,
P. Dieudé,
J. Avouac,
K. Tiev,
E. Hachulla,
B. Granel,
E. Diot,
J. Sibilia,
Luc Mouthon,
O. Meyer,
...
André Kahan,
Catherine Boileau,
Y. Allanore
|
4 |
2009 |
4
🐜
|
